Sadoff Investment Management LLC Eli Lilly & CO Transaction History

Sadoff Investment Management LLC

$1.28 Billion
Q3 2022

A detailed history of Sadoff Investment Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Sadoff Investment Management LLC holds 1,465 shares of LLY stock, worth $1.3 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

1,465

Previous 1,465 -0.0%

Holding current value

$1.3 Million

Previous $475,000 0.21%

% of portfolio

0.04%

Previous 0.04%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$234.69 - $291.66 $305,097 - $379,158	-1,300 Reduced 47.02%	1,465 $420,000
Q4 2021 Feb 02, 2022	BUY	$224.85 - $279.04 $3,372 - $4,185	15 Added 0.55%	2,765 $764,000
Q1 2021 May 11, 2021	SELL	$164.32 - $212.72 $16,432 - $21,272	-100 Reduced 3.51%	2,750 $514,000
Q3 2019 Nov 14, 2019	SELL	$106.79 - $116.16 $570,258 - $620,294	-5,340 Reduced 65.2%	2,850 $319,000
Q2 2019 Aug 07, 2019	SELL	$110.79 - $129.32 $27,697 - $32,330	-250 Reduced 2.96%	8,190 $907,000
Q1 2019 May 13, 2019	BUY	$111.31 - $131.02 $5,565 - $6,551	50 Added 0.6%	8,440 $1.1 Million
Q3 2018 Nov 14, 2018	SELL	$85.86 - $107.31 $85,860 - $107,310	-1,000 Reduced 10.65%	8,390 $900,000
Q2 2018 Aug 03, 2018	SELL	$75.7 - $86.88 $19,682 - $22,588	-260 Reduced 2.69%	9,390 $801,000
Q1 2018 Apr 26, 2018	SELL	$74.21 - $87.6 $94,617 - $111,690	-1,275 Reduced 11.67%	9,650 $747,000
Q4 2017 Feb 06, 2018	SELL	$81.94 - $87.89 $24.8 Million - $26.6 Million	-302,515 Reduced 96.51%	10,925 $923,000
Q3 2017 Nov 08, 2017	BUY	$77.07 - $85.54 $24.2 Million - $26.8 Million	313,440	313,440 $26.8 Million

Others Institutions Holding LLY

# of Institutions

3,871

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $843B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sadoff Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sadoff Investment Management LLC with notifications on news.

Account

Sadoff Investment Management LLC Eli Lilly & CO Transaction History